Article Details
Retrieved on: 2021-01-28 16:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Accelerate the development of OSE's "Immunotherapy 2.0" drug candidates by using AI, including machine learning and algorithms, at a very early stage ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here